1-5 of 5
Martin Fey
Close
Sort by
Journal Articles

Sorafenib Monotherapy Is Effective In Relapsed and RefractoryFlt3-ITD Positive Acute Myeloid Leukemia, Particularly After Allogenic Stem Cell Transplantation

Stephan Metzelder, MD, Anemone Finck, MD, Martin Fey, MD, Sebastian Scholl, MD, Matthias Kröger, MD, Andreas Reiter, MD, Helmut R. Salih, MD, Katharina Götze, MD, Ralf Georg Meyer, MD, Aristoteles Giagounidis, MD, Wolfram Brugger, MD, Matthias Vöhringer, MD, Lothar Müller, MD, Linn Yeh Ching, MD, Peter Dreger, MD, PhD, Masanori Mori, MD, Nadezda Basara, MD, Kerstin Schaefer-Eckart, MD, Beate Schultheis, MD, Claudia Baldus, MD, Andreas Neubauer, MD, Andreas Burchert, MD
Journal: Blood
Blood (2010) 116 (21): 3314.
https://doi.org/10.1182/blood.V116.21.3314.3314
Published: 2010
Journal Articles

Autologous Blood Stem Cell Transplantation Results In Better Relapse-Free Survival Than Consolidation Chemotherapy: Results of a HOVON/SAKK Phase III Trial In 519 AML Patients In First Complete Remission

Edo Vellenga, MD, PhD, Wim van Putten, MD, PhD, Gert J. Ossenkoppele, MD, PhD, Martin Fey, MD, Jurgen Kuball, MD, PhD, Matthias Theobald, MD, PhD, Jan J. Cornelissen, MD, PhD, Peter Huijgens, MD, PhD, Johan Maertens, Alois Gratwohl, MD, Martyn Ronald Schaafsma, MD, PhD, Markus G Manz, MD, Carlos Graux, MD, PhD, Bob Lowenberg, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 367.
https://doi.org/10.1182/blood.V116.21.367.367
Published: 2010
Journal Articles

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Clinical Trials & Observations
Jan J. Cornelissen, Wim L. J. van Putten, Leo F. Verdonck, Matthias Theobald, Emanuel Jacky, Simon M. G. Daenen, Marinus van Marwijk Kooy, Pierre Wijermans, Harry Schouten, Peter C. Huijgens, Hans van der Lelie, Martin Fey, Augustin Ferrant, Johan Maertens, Alois Gratwohl, Bob Lowenberg
Journal: Blood
Blood (2007) 109 (9): 3658–3666.
https://doi.org/10.1182/blood-2006-06-025627
Published: 2007
Includes: Supplemental data
Journal Articles

Factors Prognostic for Response and Event Free Survival and Treatment Related Toxicity in 306 Patients with Follicular or Mantle Cell Lymphoma Randomized to Single Agent Rituximab Given at the Standard or at a Prolonged Schedule.

Michele Ghielmini, Kaspar Rufibach, Gilles Salles, Sergio Cogliatti, Leda Leoncini-Franscini, Claire Leger-Falandry, Martin Fey, Thomas Cerny, Giovanni Martinelli, Rolf Stahel, Andreas Lohri, Nicolas Ketterer, Martin Wernli
Journal: Blood
Blood (2004) 104 (11): 588.
https://doi.org/10.1182/blood.V104.11.588.588
Published: 2004
Journal Articles

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Pierre Fenaux, Claude Chastang, Sylvie Chevret, Miguel Sanz, Hervé Dombret, Eric Archimbaud, Martin Fey, Consuelo Rayon, Françoise Huguet, Jean-Jacques Sotto, Claude Gardin, Pascale Cony Makhoul, Philippe Travade, Eric Solary, Nathalie Fegueux, Dominique Bordessoule, Jesus San Miguel, Harmut Link, Bernard Desablens, Aspasia Stamatoullas, E. Deconinck, Fréderic Maloisel, Sylvie Castaigne, Claude Preudhomme, Laurent Degos
Journal: Blood
Blood (1999) 94 (4): 1192–1200.
https://doi.org/10.1182/blood.V94.4.1192
Published: 1999